| 1 | | Primary | Miami |  US | | Therapeutics In Degenerative Disease | N/A | Maxim Temnikov | --sell technology |
| 2 | | Primary 12705 E Montview Blvd Ste. 350 | Aurora | US | | Therapeutics By Design | N/A | Kathleen Burkepile | Student at University of Colorado Boulder |
| 3 | | Primary | New York City | US | | Translating Molecules Into Therapeutics | N/A | Alain Stricker-Krongrad | C.E.O. at Envol Biomedical |
| 4 | | Primary 500 W 2nd St | Delta | US | | Craft Cbd Therapeutics | N/A | Jackson Tine | Owner at Hope CBD |
| 5 | | Primary 35 CambridgePark Dr | Cambridge | US | | Leaders In Exosome Therapeutics | N/A | Aaron Noyes | Director at Codiak BioSciences |
| 6 | | Primary 704 Quince Orchard Road | Gaithersburg | US | | Rna Therapeutics | N/A | Anthony Saleh | CEO at miRecule, Inc |
| 7 | | Primary 101 Avenue of the Americas | New York | US | | Lifelong, Resistance-Proof Therapeutics | N/A | Sayantan Bose | Senior Scientist, Virology at Autonomous Therapeutics • Former Research Fellow At Harvard Medical School |
| 8 | | Primary Im Neuenheimer Feld 515 | Heidelberg |  DE | | Transforming Ocular Therapeutics | N/A | daniela willen | director, clinical development ophthalmology |
| 9 | | Primary 383 S Colorow Dr | Salt Lake City | US | | Discovering and Developing D-Peptide Therapeutics | N/A | Neil Berkley | Vice President, Head of Business Development at Halozyme Therapeutics, Inc. |
| 10 | | Primary | San Diego | US | | A Next Generation Therapeutics Company | N/A | Brian Cajes | Head of Data and Engineering at Empirico Inc. |
| 11 | | Primary 45 Caprice Ct. | Jupiter | US | | Transforming Therapeutics | N/A | Striechman Ron | Member Of The Board Of Advisors at Beacon-Accelerator |
| 12 | | Primary Chesterford Research Park | Little Chesterford |  GB | | Excellence In Single Domain Therapeutics | N/A | David Burns | Cofounder & Director at D&R Strategic Solutions Ltd. |
| 13 | | Primary 11100 Endeavor Court | Manassas | US | | Microbiome Therapeutics | N/A | Anneke Seley | Next Generation Sales Expert and Advisor, Author, Early Oracle Digital Sales Leader, Founder of Oracle Inside Sales |
| 14 | | Primary 200 Crescent Court Suite 455 | Dallas | US | | Hedge Fund Focused On Biotech/Pharma/Therapeutics | N/A | Neil Shahrestani, MD | Portfolio Manager - Biotech/Therapeutics |
| 15 | | Primary 1 Broadway Fl 14 | Cambridge | US | | An Immune-Driven Global Bio-Therapeutics Company | N/A | musheng bao | Director |
| 16 | | Sinbuk-ro, Sinbuk-eup 61-20 | Gagnam-gu |  KR | | From Aesthetics To Therapeutics | N/A | Monica Kyong Ye Cho | HUGEL Head Of Legal/Compliance |
| 17 | | Primary 11 Scorsbey Road | Bayswater |  AU | | Delivering Quality Therapeutics | N/A | Timothee Murcier | Area Manager Asia and Middle East at Fairmont Medical Products Pty Ltd |
| 18 | | Primary London Bioscience Innovation Centre, 2 Royal College Street | LONDON | GB | | Innovative Ocular and Cancer Therapeutics | N/A | Salman Rahman | Commercial Lead at University of Hertfordshire--------President and Co-founder of VASGEN LIMITED |
| 19 | | Primary 25350 Magic Mountain Pkwy Suite #300 | Santa Clarita | US | | Digital Therapeutics For Hearing | N/A | Daehee Lee | GoldenEar Company, Inc. CEO |
| 20 | | Primary 19 Morris Ave. Building 128 | Brooklyn | US | | People-Driven Therapeutics | N/A | Stephane Castel | Co-Founder at Variant Bio |
